Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
INACTIVE
Global HQ
United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Health Tech
  • Biotechnology
About
Medicxi is a prominent venture capital firm specializing in the life sciences sector, with offices strategically located in London, St. Helier (Jersey), and Geneva. The firm is dedicated to identifying and nurturing groundbreaking companies that drive innovation in healthcare and biotechnology. With a robust focus on both venture capital and private equity, Medicxi leverages its extensive industry expertise to provide comprehensive support to its portfolio companies, fostering their growth and advancing transformative solutions in life sciences. Through its commitment to strategic investments, Medicxi aims to create lasting impact and drive progress in improving patient outcomes globally.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

Invests in early and midstage life sciences and healthcare companies with transformative potential.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Bringing extensive experience in the healthcare sector, the fund manager has actively invested in emerging markets across Europe and North America. With over 50 successful deals, their strategic approach emphasizes a data-driven investment style, focusing on growth-stage companies. Noteworthy exits include several high-profile IPOs, demonstrating a strong track record of value creation. Their thematic investment strategy targets innovative healthcare solutions, aiming to capitalize on market trends and advancements in the industry.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp